Hyperbaric oxygen Therapy
Now you can explore the synergistic benefits of IV Vitamin C and hyperbaric oxygen therapy.
Come in for an immune boost in our hyperbaric oxygen chambers.
Read more on IV Vitamin C and Hyperbaric Oxygen in these articles:
Anti-Cancer Effects of Ascorbic Acid and Hyperbaric Oxygen Therapy in vitro . "Cancer is the second leading cause of death in the U.S., projected to take 595,690 lives in 2016 and cost the nation over 125 billion dollars. To effectively reduce these detrimental losses, non-toxic, low-cost therapies should be further examined to supplement the standard of care. An anti-carcinogenic, non-toxic therapy currently under investigation is high dose ascorbic acid (AA). AA can function as a pro-oxidant at pharmacological levels, delivering H2O2 to tumorous tissue upon oxidation and initiating cell death. At pharmacological concentrations (achieved i.v.), AA has shown significant anticancer effects in vitro, in vivo, and in small-scale human reports at concentrations nontoxic to normal cells, thus having great potential as an adjuvant to the standard of care. Hyperbaric oxygen therapy (HBOT) is another non-toxic, pro-oxidant metabolic therapy that delivers 100% oxygen at elevated barometric pressure, elevating tissue pO2 and oxygenating hypoxic tumor cells, which, coupled with high levels of reactive oxygen and nitrogen species present in cancer cells, can further augment oxidative stress (OxS) and lead to cell death. This study’s aims are as follows (1) to examine the anticancer effect of AA in vitro, (2) to evaluate the mechanism of AA-induced OxS, (3) to investigate the potential synergy between AA and HBOT. We anticipate that this approach will yield significant insight into and further investigate the hypothesis that AA and HBOT can supplement the current standard of care."
"Vitamin C has been mentioned as an agent with chemotherapeutic potential since 1952. Physiological concentrations of vitamin C (L-ascorbate or L-ascorbic acid) in the body are controlled through intestinal absorption, tissue accumulation, and renal reabsorption and excretion. Therefore, intravenous administration is used to achieve pharmacologic doses not attainable by other means. In relation to intravenous administration of ascorbate, high-dose intravenous vitamin C (>0.5 g/kg body weight) has several effects: cytotoxicity for cancer cells but not for normal cells; improved quality of life for cancer patients; protection of normal tissues from toxicity caused by chemotherapy; rein¬forcement of the action of radiation and some types of chemotherapy; immune system enhancement; and strengthening of collagen and hyaluronic acid. In this article we discuss important therapeutic variables that the clinician faces that are key for increasing the effectiveness of intravenous vitamin C as an anticancer agent."
To learn more about how hyperbaric oxygen therapy can enhance your living, go to www.oxygenwell.com